Evidence map›Paper›PMID 42766344›Full record

ReviewMicrobial genomics2026

Ribosome-inactivating proteins in bacteria.

Malak H El-Ramly, Casey C Fowler

Abstract readReview
In one paragraph

Review in Microbial genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Malak H El-RamlyDepartment of Biological Sciences, University of Alberta, Edmonton, AB, T6G2E9, Canada.
Casey C FowlerDepartment of Biological Sciences, University of Alberta, Edmonton, AB, T6G2E9, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ribosome-inactivating proteins (RIPs), a group of biological toxins that depurinate a critical residue within the 28S rRNA, exhibit one of the most potent and elegant mechanisms of cellular toxicity. Examples of RIPs include ricin and Shiga toxin, which are amongst the most notorious toxins produced by plants and bacteria, respectively. Here, we discuss RIPs in the Bacteria domain. We review the biology of Shiga toxin and its role as a transformational virulence factor for some of the most virulent

Indexed as

BacteriaBacterial ProteinsRibosome Inactivating ProteinsShiga ToxinShigellaVirulence FactorsBacterial ProteinsRibosome Inactivating ProteinsShiga ToxinVirulence Factorsantifungalsexotoxinsribosome-inactivating proteinsricinShiga toxinSpiroplasmaStreptomyces

Identifiers

PMID42766344
PMCPMC13592729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.